Associate Professor, Division Chief of Urological Sciences at Yale, study prostate & bladder cancers. Dad of two corgi girls & a human boy. Views are my own.
The Mu Lab is using spatial transcriptomics/scRNA-seq-based examining, AI-based prediction, and 3D-cultured organoid-based testing to tackle questions in prostate cancer. @PCFnews @PCF_Science @YaleMed @Yale_Urology https://t.co/dN7wqI7RcR
My mentor, Dr. Charles Sawyers just delivered a stunning keynote lecture at the 1st Yale Prostate Cancer Symposium, sharing his vision for overcoming lineage plasticity and therapy resistance in prostate cancer. @YaleCancer@Yale_Urology@YaleMed@MSKCancerCenter@Yale
👏 Congratulations to our 15 Research Scholar Awardees!
The awardees are rising researchers advancing earlier detection, more personalized therapies and improved outcomes across urologic disease. This year’s awardees represent a diverse range of research areas—from cancer biology and artificial intelligence to pediatric care and infection prevention.
🔗 Click to learn more about the program and the awardees: https://t.co/LYIzitW6Yu
@WertLaboratory Most societies like ARVO usually don’t count, since membership is based on dues rather than selectivity. For your student, it may be more effective to focus on other criteria (e.g., publications, citations, reviewer activity, awards, or invited talks).
Excited to share our new work in Cancer Letters!
We identify a HOX code–based framework to define lineage plasticity across cancers and uncover RUNX1T1–HDAC reprogramming as a conserved and targetable mechanism. https://t.co/W7UzlWYJg3
Happy New Year 🎉 Started 2026 by making a Bernini-style bust of myself with AI modeling and 3D printing. Model design took <10 minutes. Ego inflation: instant. 😂
Dr. Isaac Kim, Chair of Yale Urology, gave a stunning talk on how cytoreductive radical prostatectomy plus systemic therapy can yield deep and durable benefit in ~20% of patients with metastatic prostate cancer, with Dr. Su Deng chairing the session.@Yale_Urology@SuDeng_PhD
Thrilled and deeply grateful to Yale leadership for the trust in appointing me as inaugural Chief of the Division of Urologic Sciences in our Department of Urology. Excited to work with our exceptional colleagues to drive innovation and deliver the best medicine for patients.
A true honor to present our AI-driven lineage plasticity study at the Prostate Cancer Foundation Annual Meeting. Great science, great people, and photos that make it look even cooler. 😎📸 @PCFnews@PCF_Science@Yale_Urology@YaleCancer@YaleMed@Yale
🌟 Star vs. Star! Our own Dr. Michael Leapman takes on the legendary Dr. Kaouk in the ultimate showdown: single-port vs. multi-port robotic assisted radical prostatectomy! ⚔️🤖 @Yale_Urology@YaleCancer@YaleMed@ClevelandClinic@mleapman
It was a great pleasure to visit Pfizer to present and discuss our recent findings on prostate cancer therapy resistance, and to engage with many colleagues, both old and new. I look forward to future scientific collaborations. @Yale_Urology@YaleCancer@YaleMed@Yale